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ytosolic phospholipase A
 
2
 
 (cPLA
 
2
 
)–generated arachi-
donic acid (AA) has been shown to be an essential
requirement for the activation of NADPH oxidase,
in addition to its being the major enzyme involved in the
formation of eicosanoid at the nuclear membranes. The
 
mechanism by which cPLA
 
2
 
 regulates NADPH oxidase
activity is not known, particularly since the NADPH oxidase
complex is localized in the plasma membranes of stimulated
cells. The present study is the ﬁrst to demonstrate that upon
stimulation cPLA
 
2
 
 is transiently recruited to the plasma
membranes by a functional NADPH oxidase in neutrophils
and in granulocyte-like PLB-985 cells. Coimmunoprecipita-
tion experiments and double labeling immunoﬂuorescence
C
 
analysis demonstrated the unique colocalization of cPLA
 
2
 
and the NADPH oxidase in plasma membranes of stimulated
cells, in correlation with the kinetic burst of superoxide
production. A speciﬁc afﬁnity in vitro binding was detected
between GST-p47
 
phox
 
 or GST-p67
 
phox
 
 and cPLA
 
2
 
 in lysates of
stimulated cells. The association between these two enzymes
provides the molecular basis for AA released by cPLA
 
2
 
 to
activate the assembled NADPH oxidase. The ability of
cPLA
 
2
 
 to regulate two different functions in the same cells
(superoxide generation and eicosanoid production) is
achieved by a novel dual subcellular localization of cPLA
 
2
 
to different targets.
 
Introduction
 
The NADPH oxidase is a multicomponent electron transport
chain that transfers electrons from NADPH to molecular
oxygen to form superoxide, a precursor of microbicidal oxi-
dants. The production of superoxide by NADPH oxidase is
one of the most important functions for host defense.
However, during altered physiological states reactive oxygen
products may promote inflammatory reactions and participate
in processes that lead to tissue injury. An understanding of
the biochemical processes that regulate NADPH oxidase
activity may provide a means to more effectively control
the activity of the cells during infection and inflammation.
In resting neutrophils, NADPH oxidase is dormant, with
unassembled subunits located on the cytosol and the
plasma membranes (Babior, 1999; Leto, 1999; Babior et
al., 2002). Upon stimulation, the cytosolic components
p47
 
phox
 
, p67
 
phox
 
, p40
 
phox
 
,
 
 
 
and rac2 translocate to the plasma
membranes and associate with the heterodimeric trans-
membrane glycoprotein, flavocytochrome b
 
558
 
. The cyto-
chrome is comprised of two subunits, gp91
 
phox
 
 and p22
 
phox
 
,
that contain heme, flavin, and NADPH-binding sites (Segal
and Abo, 1993; Babior, 1999; Leto, 1999; Yu et al., 1999;
Segal et al., 2000). The two cytosolic components, p47
 
phox
 
and p67
 
phox
 
, contain Src homology 3 motifs that direct
their translocation to the membranes by binding to specific
targets in p22
 
phox
 
 and to each other (Leto, 1999). p47
 
phox
 
and p40
 
phox
 
 subunits contain phox homology domains that
specifically bind to phosphatidylinositol 3,4-bisphosphate
and phosphatidylinositol 3-phosphate (Ellson et al., 2001;
Kanai et al., 2001; Sato et al., 2001). These phox homol-
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ogy domains are thought to participate in directing the
subunits to the membranes and in assembling the oxidase
complex (Ponting, 1996; Kanai et al., 2001; Stahelin et al.,
2003a).
Cytosolic phospholipase A
 
2
 
 (cPLA
 
2
 
) which hydrolyzes
phospholipids containing arachidonate at the sn-2 posi-
tion (Clark et al., 1990; Kramer et al., 1991), has been im-
plicated as the major enzyme in the formation of proin-
flammatory lipid mediators. Recently, we have created in
the human phagocyte myeloid cell line, PLB-985, a p85
cPLA
 
2
 
-deficient model cell (Dana et al., 1998) and dem-
onstrated an essential requirement for arachidonic acid
(AA) in activation of the assembled phagocyte NADPH
oxidase, the oxidase-associated H
 
 
 
 channel (Lowenthal
and Levy, 1999), and the oxidase-associated diaphorase ac-
tivity (Pessach et al., 2001) induced with a variety of ago-
nists. The normal translocation of the oxidase cytosolic
components in activated differentiated PLB-985 cells lack-
ing cPLA
 
2
 
 or in stimulated neutrophils in the presence of
PLA
 
2
 
 inhibitors (Levy et al., 1994; Dana et al., 1998; Pes-
sach et al., 2001) and the effect of PLA
 
2
 
 inhibitors even
when added after oxidase activation (Henderson et al.,
1993) indicate that cPLA
 
2
 
 is not required for translocation
of the cytosolic factors to the membranes but rather serves
a critical role in oxidase activation after the assembly of the
oxidase complex. Addition of free AA but not other free
fatty acids nor AA metabolites restored the activity, indi-
cating the specificity of AA for the process. The require-
ment of cPLA
 
2
 
 for oxidase activation is consistent with our
and other previous studies in human neutrophils and
monocytes (Henderson et al., 1993; Dana et al., 1994; Li
and Cathcart, 1997; Bae et al., 2000). In addition, a recent
study (Zhao et al., 2002) has demonstrated by the use of
antisense molecules that cPLA
 
2
 
 is absolutely required for
superoxide generation in monocytes stimulated with op-
sonized zymosan. However, that study suggests that cPLA
 
2
 
is required for translocation of oxidase cytosolic compo-
nents to the membranes and not to activation of the as-
sembled oxidase. The discrepancy may be due to the dif-
ferent roles of cPLA
 
2
 
 in the different cell types, as
proposed by the authors. In contrast to the findings dem-
onstrating requirement of the cPLA
 
2
 
 for oxidase activa-
tion, resident peritoneal macrophages from cPLA
 
2
 
-defi-
cient mice exhibited normal stimulated superoxide release
(Gijon et al., 2000), which may be attributed to either
compensatory effects of isoenzymes frequently observed in
models of knockout animals or to the known differences of
the PLA
 
2
 
 isotypes between mice and human/rat (Suzuki et
al., 2000). In an earlier study, we showed that AA increases
the affinity of the assembled oxidase in purified mem-
branes for NADPH (Rubinek and Levy, 1993). The mech-
anism by which cPLA
 
2
 
 regulates the NADPH oxidase ac-
tivity is not known, particularly since the NADPH oxidase
complex is localized in the plasma membrane in stimulated
cells, whereas cPLA
 
2
 
 has been shown to translocate to the
nuclear and ER membranes in a variety of cells (for review
see Hirabayashi and Shimizu, 2000). To elucidate the
mechanism by which cPLA
 
2
 
 regulates the activation of
NADPH oxidase, the present study investigated the cellu-
lar localization of cPLA
 
2
 
 upon stimulation and whether
 
there is any association between cPLA
 
2
 
 and the NADPH
oxidase complex during activation of phagocytic cells.
 
Results
 
Coimmunoprecipitation of cPLA
 
2
 
 with NADPH oxidase 
in membranes of activated neutrophils
 
The association between cPLA
 
2
 
 and NADPH oxidase was
studied by performing coimmunoprecipitation experiments
in resting and stimulated neutrophils with either 1 mg/ml
opsonized zymosan (OZ), 50 ng/ml PMA, or 5 
 
 
 
 10
 
 
 
7
 
 M
formyl-methionyl-leucyl-phenylalanine (fMLP). As shown
in Fig. 1, addition of antibodies against either p47
 
phox
 
 or
p67
 
phox
 
 resulted in significant immunoprecipitation of the
cytosolic components in the membrane fractions of the ac-
tivated neutrophils. cPLA
 
2
 
 was coimmunoprecipitated with
either of the cytosolic components (p47
 
phox
 
 or p67
 
phox
 
) in
the membrane fractions of activated neutrophils but not in
the membranes of resting neutrophils. In spite of the high
levels of p47
 
phox
 
 or p67
 
phox
 
 immunoprecipitated in the cyto-
sol of resting or activated neutrophils, coimmunuprecipita-
tion of cPLA
 
2
 
 was not detected. To confirm the binding be-
tween cPLA
 
2
 
 and the NADPH oxidase complex, cPLA
 
2
 
 was
immunoprecipitated, and its association with oxidase com-
ponents was analyzed. As shown in Fig. 2 A, cPLA
 
2
 
 was
immunoprecipitated in the membrane fractions of neutro-
phils activated for 1 min with either OZ, fMLP, or PMA.
The NADPH oxidase components, p47
 
phox
 
, p67
 
phox
 
, and
gp91
 
phox
 
, were coimmunoprecipitated with cPLA
 
2
 
 in the
membrane fractions of activated cells. Traces of cPLA
 
2
 
 and
the oxidase components detected in membranes of resting
cells (Figs. 1 and 2) are probably due to some basal stimula-
tion of neutrophils during purification. When cPLA
 
2
 
 im-
munoprecipitation was done with preimmune serum, nei-
ther cPLA
 
2
 
 nor the oxidase components were detected
(unpublished data), confirming the specificity of the assay.
Figure 1. Coimmunoprecipitation of cPLA2 with p67
phox or p47
phox 
in membranes of stimulated neutrophils. Neutrophils were stimulated 
with 1 mg/ml OZ, 5   10
 7M fMLP, or 50 ng/ml PMA for 1 min at 
37 C. The cell cytosol and solubilized membranes were subjected 
to immunoprecipitation (IP) with anti-p67
phox or anti-p47
phox antibodies. 
The immunoprecipitates were separated by SDS-PAGE electrophoresis, 
and immunoblotting was performed with anti-cPLA2 antibodies. The 
levels of p67
phox or p47
phox immunoprecipitated were evaluated by 
immunoblot analysis. The results shown are from one representative 
experiment out of three that gave identical results.T
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Pretreatment of neutrophils with 5 
 
 
 
g/ml cytochalasin b,
which prevents actin polimerization and disrupts cytoskele-
ton integrity (Frank, 1990; Tsai et al., 1994; Sheikh and
Nash, 1998), did not affect the binding between cPLA
 
2
 
 and
the assembled oxidase in membranes of the stimulated neu-
trophils (Fig. 2 B). Although several studies have suggested
that the functional oxidase complex at the plasma mem-
branes is associated with the cytoskeleton (Nauseef et al.,
1991; Dusi et al., 1996; Allen et al., 1999), the present
findings suggest that assembly of the NADPH oxidase com-
plex and its association with cPLA
 
2
 
 stimulated by these ago-
nists are independent of an intact cytoskeleton in nonad-
herent neutrophils. Furthermore, in accordance with these
results superoxide generation and translocation of the cyto-
solic oxidase components to membranes of nonadherent
neutrophils pretreated with cytochalasin b was increased
when stimulated with fMLP or OZ but was not affected
when stimulated with PMA (unpublished data; Dusi et al.,
1996; Yan and Novak, 1999; Jiang et al., 2000).
 
Translocation of cPLA
 
2
 
 to the plasma membranes 
of activated neutrophils
 
To determine the exact subcellular localization of cPLA
 
2
 
 af-
ter neutrophil activation, resting and stimulated cells were
fractionated onto a three-step discontinuous Percoll gradi-
ent, resulting in the separation of azurophil granules (
 
 
 
), the
specific granules (
 
 
 
1
 
 and 
 
 
 
2
 
), and the plasma membranes/
secretory vesicles (
 
 
 
). Fig. 3 demonstrates that both cPLA
 
2
 
and p47
 
phox
 
 were associated with the 
 
 
 
 fraction of PMA-
stimulated neutrophils as shown earlier for p47
 
phox
 
 (el Benna
et al., 1994; McAdara Berkowitz et al., 2001). Neutrophil
stimulation with either fMLP or OZ produced the same re-
sults (unpublished data).
 
Time course binding between cPLA
 
2
 
 and the assembled 
NADPH oxidase
 
The binding kinetics between cPLA
 
2
 
 and the assembled
NADPH oxidase were studied in peripheral blood neutro-
phils and in granulocyte-like PLB-985 cells and revealed
identical results, as shown for granulocyte-like PLB-985 cells
in Fig. 4. Immunoprecipitation of cPLA
 
2
 
 from solubilized
membrane fractions could be detected as early as 30 s after
stimulation, reaching maximal levels after 1 min of stimula-
tion with either 1 mg/ml OZ or 5 
 
 
 
 10
 
 
 
7
 
 M fMLP and de-
creasing thereafter (Fig. 4, A and C). Similar results were ob-
tained when the cells were stimulated with 50 ng/ml PMA,
with maximal levels after 3 min of stimulation (Fig. 4 B).
Since cPLA
 
2
 
 was immunoprecipitated from the membranes,
its level dictated the levels of coimmunoprecipitated p47
 
phox
 
and p67
 
phox
 
 (Fig. 4, A–C). Thus, the time course appearance
of cPLA
 
2
 
, p47
 
phox
 
, and p67
 
phox
 
 to the membranes after stimu-
lation was analyzed in order to compare translocation kinet-
ics of these proteins. As shown in Fig. 4, D–F, the oxidase
cytosolic components were rapidly and simultaneously
translocated to the solubilized membrane fractions after stim-
ulation, preceding the translocation of cPLA
 
2
 
. These results
are in line with our previous studies (Levy et al., 1994; Dana
et al., 1998; Pessach et al., 2001), demonstrating that the
translocation of the oxidase cytosolic components is indepen-
dent of cPLA
 
2
 
. As shown in Fig. 4, D–F, the kinetics of
cPLA
 
2
 
 translocation to the membranes is dependent on the
translocation of the kinetics of oxidase cytosolic components
and is more rapid when stimulated with OZ or fMLP than
with PMA, which is consistent with the development of the
burst of superoxides by these agonists (Fig. 4, G–I). Signifi-
cant translocation of cPLA
 
2
 
 to the membranes of stimulated
cells was detected before the production of superoxides,
whereas maximal translocation of cPLA2 was detected at 1
min of stimulation with OZ or fMLP and at 3 min of stimu-
lation with PMA (Fig. 4, D–F), which coincided with the
onset of superoxide production by these three agonists (Fig.
4, G–I). The detachment of cPLA2 from the membrane frac-
tions precedes that of the cytosolic components p47
phox and
p67
phox (Fig. 4, D–F) and takes place while NADPH oxidase
is still being activated to generate superoxide (Fig. 4, G–I).
To determine the molar ratio between the assembled oxi-
dase and cPLA2 in the membranes after stimulation, the lev-
Figure 2. Coimmunoprecipitation of 
NADPH oxidase components with cPLA2 
in membranes of activated neutrophils. 
Neutrophils (A) and neutrophils (B) 
preincubated with 5  g/ml cytochalasin 
b for 10 min at 37 C were stimulated as 
in the legend to Fig. 1. cPLA2 immuno-
precipitation (IP) was performed in 
solubilized neutrophil membranes, 
applied to SDS-PAGE electrophoresis, 
and followed by immunoblotting with 
anti-gp91
phox, anti-p67
phox, and anti-p47
phox antibodies. The levels of cPLA2 immunoprecipitated were evaluated by immunoblot analysis. The 
results shown are from one representative experiment out of three that gave identical results. (C) Immunoblot of cPLA2 in neutrophil lysates. 
Preimmune serum (pre) did not detect any protein, whereas the antibodies raised against cPLA2 detected one band in the neutrophil lysates.
Figure 3. Subcellular localization of cPLA2 in neutrophils. 5   10
8 
neutrophils, either unperturbed or stimulated with PMA, were 
disrupted by N2 cavitation. The postnuclear supernatant was loaded 
on a three-layer Percoll gradient. The  ,  1,  2, and   fractions were 
formed as described in Materials and methods, separated on SDS-
PAGE electrophoresis, and subjected to immunoblot analysis with 
anti-p47
phox and anti-cPLA2 antibodies. The results are from one 
representative experiment out of three that gave identical results.T
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els of cPLA2 and of p47
phox (which are representative of the
assembled oxidase) in the same membranes from stimulated
neutrophils were analyzed by quantitative Western blotting
as done by others (Quinn et al., 1993). Representative blots
and standard curves obtained by quantitative densitometry
of recombinant proteins are shown in Fig. 5. Quantitative
analysis revealed that cPLA2 and p47
phox translocated to the
membranes by the three agonists at a molar ratio of 1:25.
Actual measured values for cPLA2 derived from the standard
curves were 2.1, 1.6, or 2.3 ng/sample, which were calcu-
lated as 25, 20, or 28 pmoles/sample in the membranes from
neutrophils stimulated with OZ, fMLP, or PMA, respec-
tively. Actual measured values for p47
phox derived from the
standard curves were 28, 23, or 31 ng/sample, which were
calculated as 604, 504, or 673 pmoles/sample in the mem-
branes from cells stimulated with OZ, fMLP, or PMA, re-
spectively. Despite the different levels of p47
phox translocated
to the membrane induced by the different agonists, the mo-
lar ratio between cPLA2 and p47
phox was similar, indicating
that the level of p47
phox determines the level of cPLA2 that
translocates to the membranes. Similar results were obtained
in granulocyte-like PLB-985 cells.
In vivo location of cPLA2 in resting and activated cells
Based on the in vitro binding between cPLA2 and NADPH
oxidase in plasma membranes of stimulated cells, we exam-
ined the in vivo location of cPLA2 in resting and activated
cells by immunofluorescence microscopy. Granulocyte-like
PLB-985 cells are advantageous for the study: first, the expres-
sion of gp91
phox can be manipulated in these cells (Zhen et al.,
1993), thus enabeling determination of the role of oxidase for
targeting cPLA2 to the plasma membranes, and second, PLB-
985 cells differentiated with DMSO exhibit different kinetics
for superoxide production (Fig. 4) and for eicosonoid forma-
tion (shown at the end of this section), thus facilitating a
means to detect the location of cPLA2 in different compart-
ments after stimulation. Double staining immunofluores-
cence analysis of cPLA2 and the membrane oxidase compo-
nent gp91
phox showed that cPLA2 is found in the cytosol of
resting granulocyte-like PLB-985 cells (Fig. 6 A). Upon stim-
ulation with either PMA, OZ, or fMLP, a significant translo-
cation of cPLA2 to the cell periphery was detected where it
colocalized with gp91
phox, confirming the localization of
cPLA2 in the plasma membranes of activated phagocytic cells.
No increase in the gp91
phox immunofluorescence signal was
detected after stimulation with either of the agonists (Fig. 6
A), which is in line with the low levels of granules, including
gp91
phox endomembranes, present in PLB-985 cells differenti-
Figure 4. The time course association 
and translocation of cPLA2 and the 
cytosolic components of NADPH oxidase 
in membranes of stimulated granulocyte-
like PLB-985 cells. PLB-985 cells were 
differentiated with 1.25% DMSO for 4 d. 
The cells were stimulated with 1 mg/ml 
OZ (A), 50 ng/ml PMA (B), or 5   10
 7 M 
fMLP (C) for the indicated times at 37 C. 
The cell membranes were subjected to 
immunoprecipitation (IP) with anti-cPLA2 
antibodies, followed by immunoblot of 
p67
phox and p47
phox. The bottom lane in 
each experiment shows the levels of cPLA2 
detected in the immunoprecipitates. 
Time course translocation of cPLA2, 
p67
phox, and p47
phox to cell membranes 
after stimulation with OZ (D) PMA (E), or 
fMLP (F) was detected by immunoblot 
analysis. 2   10
6 cell membrane equivalent were applied per lane. Superoxide production stimulated with either OZ (G), PMA (H), or fMLP 
(I) as detected by cytochrome C reduction. The results are from one representative experiment out of three presenting identical results.
Figure 5. The molar ratio between cPLA2 and NADPH oxidase in 
the membranes of stimulated cells. Samples of recombinant cPLA2 
or p47
phox and membranes (bottom inset) of neutrophils stimulated 
with 1 mg/ml OZ, 5   10
 7 M fMLP for 1 min or 50 ng/ml PMA for 
3 min (top inset) were analyzed by SDS-PAGE electrophoresis. 2   10
6 
cell membrane equivalents were applied per lane. The Western 
blots were analyzed using quantitative densitometry, and the relative 
optical density of each band was plotted against the amount of protein 
added per lane. The correlation coefficient for the cPLA2 standard 
curve is 0.99 and for the p47
phox standard curve is 0.92. The quantities 
of cPLA2 and p47
phox in membranes of stimulated cells were 
determined from the standard curves. The results are from one 
representative experiment out of three presenting identical results.T
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ated with DMSO but in contrast to PLB-985 cells differenti-
ated with 1,25(OH)2D3 (unpublished data) or to PLB-985
cells differentiated with DMF (Pedruzzi et al., 2002). The ki-
netics of cPLA2 translocation stimulated with fMLP is de-
picted in Fig. 6 B. Maximal levels of cPLA2 were detected in
the cell periphery 1 min after stimulation. 5 min after stimu-
lation, a significant fraction of cPLA2 reappeared in the cyto-
sol. This subcellular localization of cPLA2 stimulated with
fMLP is similar to that detected by immunoblotting analysis
(Fig. 4 D). The immediate translocation of cPLA2 to the
membranes correlates with the rapid onset of superoxide
upon stimulation (Fig. 4). Translocation of cPLA2 to the nu-
cleus was studied by double labeling of cPLA2 and of lamin B
as a marker for nuclear membranes (Olins et al., 2001). As
shown in Fig. 6 C, activation of the cells with fMLP for 15
min induced translocation of cPLA2 to the nuclear mem-
branes where it colocalized with lamin B. To determine the
kinetics of cPLA2 translocation to the nuclear membranes, the
nuclei of cells stimulated for different time duration were sep-
arated and analyzed for the presence of cPLA2 by immunoblot
analyses. Translocation of cPLA2 to the nuclear membranes
could be detected only 15 min after stimulation, in correla-
tion with the time course of PGE2 secretion as shown in Fig.
6 D, which depicts stimulation of granulocyte-like PLB cells
with fMLP. Similar results were obtained with PMA and OZ
(unpublished data).
The role of NADPH oxidase in targeting cPLA2 to the 
plasma membranes
To determine the role of NADPH oxidase in directing
cPLA2 to the plasma membranes, we studied the subcellular
location of cPLA2 in granulocyte-like gp91
phox-deficient
PLB-985 cells in which no oxidase assembly occurs (Biber-
stine-Kinkade et al., 1999). As shown by immunoblot analy-
sis, cPLA2 could not be detected in membranes of granulo-
cyte-like gp91
phox-deficient PLB-985 cells stimulated for 1
min with OZ, PMA, or fMLP, whereas it was clearly de-
tected in membrane fractions of stimulated granulocyte-like
PLB-985 cells (Fig. 7 A). These results were confirmed by
Figure 6. Subcellular localization of cPLA2 in stimulated granulocyte-like PLB-985 cells. (A) Granulocyte-like PLB-985 cells before and after 
stimulation with 1 mg/ml OZ, 5   10
 7 M fMLP for 1 min or 50 ng/ml PMA for 3 min at 37 C were fixed, permeabilized, and incubated with 
anti-cPLA2 and anti-gp91
phox antibodies and then with cy3- and cy2-conjugated second antibodies, respectively. cPLA2 was found in the 
cytosol in resting cells and colocalized with gp91
phox in the plasma membranes in stimulated cells. An engulfed OZ particle (stained in red as 
indicated by the white arrow) is surrounded by plasma membranes in which gp91
phox and cPLA2 colocalized ( 1,000). (B) The time course 
translocation of cPLA2 to cell periphery after stimulation with 5   10
 7 M fMLP ( 400). (C) Lamin B was labeled by anti–lamin B antibodies 
and then with cy2-conjugated second antibodies. cPLA2 colocalized with lamin B in nuclear membranes of stimulated cells with 5   10
 7 M 
fMLP for 15 min ( 1,000). (D) The kinetics   SEM of PGE2 production (of three experiments, each in triplicates) and of cPLA2 translocation to 
the nuclear fractions (a representative immunoblot analysis of the three experiments) in 5   10
6 cells/ml granulocyte-like PLB-985 cells after 
stimulation with 5   10
 7 M fMLP. 2   10
6 cell equivalent of nuclear fraction was applied in each lane. Equal amounts of the nuclear fractions 
were confirmed by detection of the levels of lamin B in each sample by immunoblot analysis.T
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confocal laser scanning microscopy, demonstrating that
granulocyte-like gp91
phox-deficient PLB-985 cells indeed do
not express any gp91
phox (Fig. 7 B) and that their stimulation
with either of the three agonists does not induce any translo-
cation of cPLA2 to the cell periphery (Fig. 7 C). However,
after expression of retroviral gp91
phox protein in these cells,
cPLA2 translocation to the cell periphery was fully restored
(Fig. 7 C), thereby establishing the role of a functional oxi-
dase for targeting cPLA2 to the plasma membranes.
In vitro interaction between cytosolic oxidase 
components and cPLA2
To determine affinity binding between cPLA2 and the oxi-
dase components, GST-p47
phox and GST-p67
phox fusion
proteins were used. As shown in Fig. 8, cPLA2 was pulled
down from lysates of stimulated, but not resting, neutrophils
by either GST-p47
phox or GST-p67
phox fusion protein but
not from lysates of resting cells, suggesting that the binding
occurs only with the phosphorylated form of cPLA2. In ad-
dition, p67
phox was also pulled down by GST-p47
phox fusion
protein, and p47
phox was pulled down by GST-p67
phox fu-
sion protein. These experiments demonstrate the in vitro af-
finity binding between cPLA2 and the oxidase cytosolic
components but do not determine whether cPLA2 is asso-
ciated independently with both p47
phox and p67
phox or
whether it is bound to one cytosolic component and takes
up the other, since p47
phox and p67
phox are found in a com-
plex at the membranes of activated cells. Similar results were
obtained in granulocyte-like PLB-985 cells (unpublished
data). Although cPLA2 was specifically bound to each of the
oxidase cytosolic components in vitro using recombinant
GST fusion proteins, such binding between cPLA2 and the
soluble p47
phox and p67
phox in the cytosol did not occur in
physiological conditions (Fig. 1). Rather cPLA2 binds the
cytosolic oxidase components when found in the assembled
NADPH oxidase after translocation to the plasma mem-
branes, in accordance with our previous study demonstrat-
ing that the assembly of the oxidase is independent of cPLA2
(Dana et al., 1998). The behavior of the recombinant GST-
fused cytosolic proteins may reflect the effects of the fusion
on the conformation and exposure of sites interacting with
cPLA2 that become exposed in the native proteins only when
forming membrane complexes after cell stimulation.
Discussion
The results of the present study are the first to demonstrate
that in granulocytic cells, which contain abundant levels of
NADPH oxidase, stimulation induces an immediate and
transient recruitment of cPLA2 to the plasma membranes, in
addition to its already known translocation to the nuclear
Figure 7. Absence of gp91
phox in the cell membrane prevents 
cPLA2 translocation to the plasma membranes. (A) Granulocyte-like 
PLB-985 and granulocyte-like gp91
phox-deficient PLB-985 cells were 
stimulated as in the legend to Fig. 1. The cell membranes were 
separated on 10% SDS-PAGE and subjected to Western blot analysis 
against cPLA2. The results are from one representative experiment 
out of three that gave identical results. (B) Resting granulocyte-like 
and granulocyte-like gp91
phox-deficient PLB-985 cells were double 
stained as in the legend to Fig. 6 A. cPLA2 is found in the cytosol of 
both type of cells, whereas gp91
phox was detected only in granulocyte-
like PLB-985 cells. (C) Granulocyte-like gp91
phox-deficient PLB-985 
cells and the cell line expressing retroviral gp91
phox differentiated 
toward the granulocytic lineage before and after stimulation (as in 
the legend to Fig. 1) were double stained (as in the legend to Fig. 6 A). 
cPLA2 is found in the cytosol before and after activation in gp91
phox-
deficient PLB-985 cells but translocates to cell periphery after 
stimulation following the expression of retroviral gp91
phox protein 
in these cells.
Figure 8. Binding between cPLA2 and cytosolic oxidase components. 
Affinity-binding assay using GST-p67
phox or GST-p47
phox was 
performed as described in Materials and methods. GST-p67
phox 
binds p47
phox in lysates of resting and stimulated neutrophils (with 
50 ng/ml PMA) and binds cPLA2 only in lysates of stimulated cells, 
whereas GST alone was not effective. Similarly, GST-p47
phox binds 
p67
phox in lysates of resting and stimulated cells and binds cPLA2 
only in lysates of stimulated cells.T
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membranes (Marshall et al., 2000). The translocation of
cPLA2 to the membrane fractions of stimulated neutrophils
has been shown earlier by us and by others (Durstin et al.,
1994; Hazan et al., 1997; Marshall et al., 2000). In addi-
tion, several studies performed in a variety of cells including
platelets, fibroblasts, and keratinocytes (Kast et al., 1993;
Schalkwijk et al., 1995; McNicol and Shibou, 1998; Kita-
tani et al., 2000) have reported translocation of cPLA2 to
membrane fractions. However, the present study demon-
strates that cPLA2 is localized in the plasma membranes
upon stimulation. The absence of cPLA2 translocation to the
plasma membranes in granulocyte-like gp91
phox-deficient
PLB-985 cells and the restoration of cPLA2 translocation, af-
ter the expression of retroviral gp91
phox protein, indicate that
NADPH oxidase is responsible for anchoring cPLA2 to the
plasma membranes. The translocation of cPLA2 to the mem-
branes occurred after assembly of the oxidase and coincided
with the onset of superoxide production (Fig. 4). The affin-
ity binding between GST-p47
phox or GST-p67
phox with
cPLA2 only in lysates of stimulated cells (Fig. 8) suggests a
direct binding with cPLA2 in its phosphorylated form. In
earlier studies (Dana et al., 1998), we have shown that AA
by itself and not its metabolites is required for activation of
the assembled NADPH oxidase enzyme. The colocalization
of both enzymes (the assembled NADPH oxidase and
cPLA2) in the same compartment and their direct binding
during the onset of superoxide production provides a means
by which AA released by cPLA2 is able to activate the assem-
bled NADPH oxidase. The precise mechanism by which AA
regulates the NADPH oxidase in whole cells is not yet
known. Several studies suggest that AA induces structural
changes in NADPH oxidase components that may promote
productive interaction between the different oxidase sub-
units, thereby enabling full oxidase activation or directly af-
fecting the function of flavocytochrome b (Foubert et al.,
2002). The 1:25 molar ratio between cPLA2 to the assem-
bled oxidase in the membranes of stimulated cells (Fig. 5)
indicates that one copy of cPLA2 is able to provide sufficient
levels of AA for several copies of the NADPH oxidase found
in its environment. Our current observations are most con-
sistent with a model in which cPLA2-generated AA might be
a cofactor acting in the intact phagocytic cell to enhance the
affinity of the assembled NADPH oxidase for NADPH (Ru-
binek and Levy, 1993) probably by induction of structural
changes. cPLA2 dissociates from the membranes before the
oxidase cytosolic components (Fig. 4, D–F) and while the
oxidase is still functioning (Fig. 4, G–I), suggesting that
cPLA2 is required for the activation of NADPH oxidase but
not for maintaining its activity.
Recent studies have suggested that cPLA2 has three func-
tionally distinct domains: an NH2-terminal C2 domain nec-
essary for Ca
2 -dependent phospholipid binding, a COOH-
terminal Ca
2 -independent catalytic region (Nalefski et al.,
1994), and a putative pleckstrin homology domain within
this region that is responsible for the interaction with phos-
phatidylinositol 4,5-bisphosphate (PtdIns[4,5]P2; Mosior et
al., 1998). Subcellular localization of the various C2 do-
mains upon cytoplasmic [Ca
2 ] elevation has been shown to
correlate with their phospholipid binding specificity. It has
also been shown that the cPLA2-C2 domain has specificity
to the phosphatidylcholine-rich nuclear envelope and ER
(Gijon et al., 1999; Perisic et al., 1999; Hurley and Misra,
2000) and that aromatic and hydrophobic residues in the
calcium binding loop of the cPLA2-C2 domain are impor-
tant for its lipid specificity (Stahelin et al., 2003b). In con-
trast, the PKC -C2 domain has specificity to the phosphati-
dylserine-rich plasma membranes (Oancea and Meyer,
1998; Corbalan-Garcia et al., 1999) and ASn
189 plays a key
role in this specificity (Stahelin et al., 2003b). Several studies
have shown that cPLA2 translocates from the cytosol to the
nuclear membrane and to the ER by calcium ionophores or
agonists such as histamine or IgE/antigen, which increase
cytoplasmic [Ca
2 ] in a variety of cells (Peters-Golden and
McNish, 1993; Glover et al., 1995; Schievella et al., 1995;
Sierra-Honigmann et al., 1996). However, PMA, which
does not induce an increase in cytoplasmic [Ca
2 ], caused
activation and translocation of cPLA2 (Hazan et al., 1997;
Qiu et al., 1998), suggesting the existence of alternative
pathways that induce translocation of cPLA2 not involving
elevation of cytoplasmic [Ca
2 ], which is necessary for the
C2 domain phospholipid binding. The results of our present
study suggest that the cPLA2-C2 domain does not partici-
pate in the translocation of cPLA2 to the plasma membranes,
since cPLA2 translocation is inconsistent with its C2 domain
phospholipid binding specificity. In addition, cPLA2 trans-
location to the cell periphery did not occur in the absence of
a functional NADPH oxidase (Fig. 7), and it can be induced
with PMA (Fig. 3 and Fig. 6 A), which does not cause eleva-
tion of cytoplasmic [Ca
2 ]. However, we cannot rule out the
possibility that the binding of cPLA2 to the assembled oxi-
dase is mediated through the cPLA2-C2 domain. Similar to
our observation that the C2 domain–containing cPLA2
binds NADPH oxidase, a recent study (McAdara Berkowitz
et al., 2001) has shown that C2 domain–containing protein
JFC1, which is restricted to the plasma membranes/secretory
vesicles, binds p67
phox without affecting the interaction be-
tween p47
phox and p67
phox. High levels of PtdIns(4,5)P2 have
been detected in neutrophil plasma membranes upon stimu-
lation (Botelho et al., 2000; Martin, 2001), and PtdIns(4,5)P2
has been shown to display a particularly dramatic effect on
the activity of cPLA2 (Mosior et al., 1998). However, it
seems that the cPLA2 pleckstrin homology domain by itself
does not play a critical role in targeting cPLA2 to the plasma
membranes, since in the absence of the functional oxidase
cPLA2 did not translocate to this compartment, as shown in
gp91
phox-deficient granulocytic PLB-985 cells (Fig. 7). Thus,
the assembled NADPH oxidase appears to be the major de-
terminant in directing cPLA2 to the plasma membranes, al-
though the interaction sites among cPLA2, NADPH oxi-
dase, and the plasma membranes are not yet defined.
Eicosanoid generation has been shown to be regulated in
part by perinuclear envelope localization or translocation of
individual enzymes of leukotriene and prostaglandin biosyn-
thesis (Ueno et al., 2001). The perinuclear translocation of
cPLA2, shown in a variety of cells, is in agreement with its
role in leukotriene and prostaglandin formation. Similarly,
our present study demonstrates a correlation between the ki-
netics of cPLA2 translocation to nuclear membranes and
PGE2 production in stimulated granulocyte-like PLB-985
cells (Fig. 6, C and D). The differences in the kinetics of su-T
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peroxide production and PGE2 formation in PLB-985 cells
differentiated with DMSO enabled us to efficiently follow
the distribution of cPLA2 during stimulation, from early
translocation to the cell periphery to later translocation to
the nuclear envelope. Thus, the mechanism which permits
the participation of cPLA2 in two different processes in the
same cell (regulation of NADPH oxidase and eicosanoid
production) is controlled by localization of the enzyme in
different subcellular compartments.
In conclusion, the use of combined biochemical and mi-
croscopical approaches enhanced our ability to gain better
insight into cellular processes and to clearly demonstrate that
upon activation of peripheral blood neutrophils and granu-
locyte-like PLB-985 cells, both of which contain abundant
levels of NADPH oxidase, cPLA2 translocates to the plasma
membranes where it binds the assembled oxidase complex
and releases AA, which promotes oxidase activity. The ab-
sence of cPLA2 in the cell periphery of stimulated granulo-
cyte-like gp91
phox-deficient PLB-985 cells and its transloca-
tion after the expression of retroviral gp91
phox protein in
these cells indicate that cPLA2 is anchored to the plasma
membranes by the assembled oxidase. The physical associa-
tion between these two enzymes enables the regulation of
NADPH oxidase by cPLA2-generating AA. The novel dual
subcellular localization of cPLA2 in different compartments,
first in the plasma membranes and then in the nucleus, pro-
vides a molecular mechanism for the participation of cPLA2
in different processes in the same cells. The exact binding
sites between these two enzymes and the target for AA action
are currently under investigation.
Materials and methods
Neutrophil purification
Neutrophils were separated by Ficoll/Hypaque centrifugation, dextran sed-
imentation, and hypotonic lysis of erythrocytes (Dana et al., 1998).
Cell culture and differentiation
PLB-985 and gp91
phox-deficient PLB-985 cells lacking the expression of
normal gp91
phox (provided by M.C. Dinauer, James Whitcomb Riley Hos-
pital for Children, Indianapolis, IN) were grown in stationary suspension
culture in RPMI-1640 as described earlier (Dana et al., 1998). The optimal
concentration of 1.25% of DMSO was added to 2   10
5 PLB-985 cells/ml
at their logarithm growth phase to induce differentiation toward the granu-
locyte phenotype. Mac-1 antigen determination was detected by indirect
immunofluorescence as described previously (Hazav et al., 1989).
Isolation of membrane and cytosol fractions
Neutrophils were suspended at 10
7 cells/ml in phosphate buffer saline and
treated with 5 mM diisopropylfluorophosphate for 30 min at room temper-
ature before stimulation. Membrane and cytosol fractions were prepared
as described previously (Levy et al., 1990).
Immunoprecipitation
Goat antiserum raised against recombinant p47
phox or p67
phox (Leto et al.,
1991) or rabbit antiserum raised against cPLA2 (Hazan et al., 1997) was
added to 3   10
7 membranes or cytosol cell equivalents in 500  l solubi-
lization buffer (150 mM NaCl, 5 mM EDTA, 10 mM Tris, pH 7.5, 1% so-
dium deoxycholate, and 1% NP-40), and they were incubated on ice over-
night. The extracts were brought to a volume of 1 ml in solubilization
buffer containing 30  l of 50% slurry of recombinant protein G–sepha-
rose. The samples were tumbled end-over-end for 1 h and washed twice
with 1 ml solubilization buffer containing 20% (wt/vol) sucrose and 0.15%
(wt/vol) BSA and twice with 1 ml solubilization buffer containing 20% su-
crose. The samples were boiled in SDS sample buffer and electrophoresed
on a 10 or 7% SDS-PAGE. For detection of protein translocation, cell
membranes (2   10
6 cell equivalent) were separated by SDS-PAGE elec-
trophoresis. The resolved proteins were electrophoretically transferred to
nitrocellulose, and the detection of cPLA2 or the oxidase components was
analyzed as described previously (Hazan et al., 1997).
Subcellular fractionation
Subcellular fractionation was performed as described by others (Kjeldsen
et al., 1999). Neutrophils (5   10
8) treated with diisopropylfluorophos-
phate were suspended in relaxation buffer (as described earlier; Levy et al.,
1990) and disrupted by nitrogen cavitation at 400 pounds per square inch.
Nuclei and unbroken cells were pelleted by centrifugation at 500 g for 10
min at 4 C. The supernatant was decanted and loaded onto a precooled
discontinuous density gradient Percoll, and 10  concentrated relaxation
buffer and distilled water were mixed to give solutions of densities of 1.05,
1.09, and 1.12 g/ml. The gradients were centrifuged at 32,800 g for 35 min
at 4 C using a fixed angle Beckman Coulter JA20 rotor. Four visible bands
were collected, and the markers for azurophil granules ( ), specific gran-
ules ( ), and plasma membranes ( ) were analyzed as described previously
(Kaufman et al., 1996).
Immunofluorescence microscopy
Preparation of labeled cells was done as described by others (Bingham et
al., 1999) with some modification. Cells were adhered on coverslips for 30
min at 37 C. The cells were stimulated with various agonists for the de-
sired duration and fixed with 3% (wt/vol) formaldehyde. The first antibod-
ies against cPLA2, gp91
phox, and lamin B (Santa Cruz Biotechnoloy) dis-
solved in PBS containing 0.2% saponin were added for 1 h at room
temperature. cy2- or cy3-conjugated antibodies (Jackson ImmunoResearch
Laboratories) were used as secondary antibodies. The fluorescence was vi-
sualized using a four channel Zeiss LSM 510 laser scanning confocal mi-
croscope (Carl Zeiss MicroImaging, Inc.). The LSM 510 software was used
for imaging cPLA2, gp91
phox, and lamin B localization.
Retroviral transduction of gp91
phox-deficient PLB-985 cells
Retroviaral gp91
phox was expressed in gp91
phox-deficient PLB-985 cells
(Zhen et al., 1993) as done in our previous study (Pessach et al., 2001).
Affinity-binding assay
The GST fusion proteins were affinity purified on glutathione-sepharose as
described previously (Leto et al., 1994). 50  l (1  g) of GST-p47
phox or
GST-p67
phox bound to glutathione-sepharose beads was added to lysates of
5   10
7 resting or stimulated neutrophils prepared as described before
(Hazan-Halevy et al., 2000) and was tumbled end-over-end for 2 h at 4 C.
Bound proteins were washed three times in 15 vol of ice cold 100 mM
KCl, 3 mM NaCl, 3.5 mM MgCl2, 0.15 mM PMSF, and 10 mM Pipes (pH
7.5), eluted with 2% SDS, and analyzed by SDS-PAGE followed by immu-
noblotting with the appropriate antibodies.
Superoxide anion measurements
The production of superoxide anion (O2
 ) by intact cells was measured as
the superoxide dismutase inhibitable reduction of ferricytochrome c (Dana
et al., 1998).
Preparation of nuclei
Nuclei were separated from granulocyte-like PLB cells (2   10
7 cells) be-
fore and after stimulation as described by others in neutrophils (Surette et
al., 1998). Stimulated cells were pelleted and resuspended in 600  l of
ice-cold NP-40 lysis buffer (0.1% NP-40, 10 mM Tris-HCl, pH 7.4, 10 mM
NaCl, 3 mM MgCl2, 1 mM EDTA, 10  g/ml leupeptin, 10  g/ml aprotonin,
and 1 mM PMSF). The cells were vortexed for 15 s, kept on ice for 5 min,
and centrifuged at 300 g for 10 min at 4 C. The resulting pellets (the nuclei
containing fractions) were then immediately solubilized in electrophoresis
sample buffer and processed for SDS-PAGE and immunoblot determina-
tion of cPLA2 and the nuclear lamin B. Nuclear integrity was verified di-
rectly by light microscopy, which also revealed that intact cells were rarely
observed in nuclei-containing fraction ( 2%).
PGE2 determination
PGE2 levels were determined in the supernatant of stimulated cells by RIA
using commercial kits (NEN Life Science Products). The samples were im-
mediately stored at  70 C and analyzed during 1 wk of the experiments.
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